Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412054
What this trial is testing

Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Fudan University 234
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT04039607
What this trial is testing

Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 732
Testing effectiveness (Phase 2)Study completedNCT03086564
What this trial is testing

A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)

Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 70
Testing effectiveness (Phase 2)WithdrawnNCT01953406
What this trial is testing

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLung Metastasis
Seoul National University Hospital
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Post-approval studies (Phase 4)Ended earlyNCT01760616
What this trial is testing

Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy

Who this might be right for
Hepatic Carcinoma
Qidong Gaitianli Medicines Co., Ltd 790
Testing effectiveness (Phase 2)Study completedNCT01714609
What this trial is testing

The Effect of Sorafenib on Portal Pressure

Who this might be right for
Clinically Significant Portal Hypertension
Yale University 10
Testing effectiveness (Phase 2)UnknownNCT04224636
What this trial is testing

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich 106
Testing effectiveness (Phase 2)Study completedNCT01192971
What this trial is testing

Apatinib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 121
Not applicableStudy completedNCT01798134
What this trial is testing

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 25
Not applicableWithdrawnNCT01710293
What this trial is testing

Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis

Who this might be right for
Lung CancerBladder CancerColorectal Cancer+2 more
VA Office of Research and Development
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)UnknownNCT03510416
What this trial is testing

Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
Shanghai Zhongshan Hospital 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07350070
What this trial is testing

TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension

Who this might be right for
HCCLiver CirrhosisPortal Hypertension
Tongji Hospital 78
Not applicableStudy completedNCT04172194
What this trial is testing

Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas

Who this might be right for
Carcinoma, Hepatocellular
Centre Hospitalier Universitaire de Nice 64
Not applicableUnknownNCT01930383
What this trial is testing

Circulating Tumor Cells for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularNeoplasm Circulating Cells
National Taiwan University Hospital 150
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Not applicableUnknownNCT05575622
What this trial is testing

Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongnan Hospital 200
Next Page